1. Markers of Differential Response to Inhaled Corticosteroid Treatment Among Children with Mild Persistent Asthma 
Joe K. Gerald, MD, PhD, Lynn B. Gerald, PhD, MSPH, Monica M. Vasquez, MPH, MEd, Wayne J. Morgan, MD, Susan J. Boehmer, MA, Robert F. Lemanske, MD, David T. Mauger, PhD, Robert C. Strunk, MD, Stanley J. Szefler, MD, Robert S. Zeiger, MD, Leonard B. Bacharier, MD, Elizabeth Bade, MD, Ronina A. Covar, MD, Theresa W. Guilbert, MD, Hengameh Heidarian-Raissy, PharmD, H. William Kelly, PharmD, Jonathan Malka-Rais, MD, Christine A. Sorkness, PharmD, Lynn M. Taussig, MD, Vernon M. Chinchilli, PhD, Fernando D. Martinez, MD 
The Journal of Allergy and Clinical Immunology: In Practice 
Volume 3, Issue 4, Pages e3 (July 2015)
DOI: /j.jaip
Copyright © 2015 American Academy of Allergy, Asthma & Immunology Terms and Conditions

2. Figure 1
HR of TFE among participants treated with a daily inhaled corticosteroid as compared with placebo stratified by skin test result status.
The Journal of Allergy and Clinical Immunology: In Practice 2015 3, e3DOI: ( /j.jaip )
Copyright © 2015 American Academy of Allergy, Asthma & Immunology Terms and Conditions

3. Figure 2
Mean change in ACDs among participants treated with a daily inhaled corticosteroid as compared with placebo stratified by sex, skin test result status, IgE level, and run-in asthma control.
The Journal of Allergy and Clinical Immunology: In Practice 2015 3, e3DOI: ( /j.jaip )
Copyright © 2015 American Academy of Allergy, Asthma & Immunology Terms and Conditions